*White, but Not Innocent? The Titanium Dioxide Story* 💊 Titanium dioxide (TiO₂) has been the silent workhorse behind pharma’s pristine white tablets for decades. But after the EU banned it in food, its future in medicines turned uncertain. Fast forward to 2025 — the *European Commission reaffirmed TiO₂’s use in pharmaceuticals*, admitting that no replacement yet delivers its balance of *opacity, stability, and safe…

Channel
Inpharmedia
@inpharmedia
On this record: Topic · Growth · Engagement · Posts · Cite this entry
128subscribers
-2 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
Register entry
| Telegram ID | -1001281880110 |
|---|---|
| Type | Channel |
| Username | @inpharmedia |
| Created | Between 1 April 2018 and 31 August 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 9 August 2026 |
| Last confirmed live | 10 October 2026 |
| Measurements held | 4 |
| Confirmed unchanged | 2 times, most recently 10 October 2026 |
| On Telegram | t.me/inpharmedia |
Topic
Other / unclassifiable — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 26 September 2026 and assigned it the closest of 31 fixed categories, at 48% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 29 Sept 2026, 08:20 | 128 | -1 |
| 8 Sept 2026, 05:16 | 129 | -1 |
| 9 Aug 2026, 01:16 | 130 | no change |
| 7 Aug 2026, 21:26 | 130 | first reading |
Engagement
20 posts held, back to 7 March 2025 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 10 November 2025. An engagement rate over an empty window would be a number about nothing.
Recent posts
https://www.linkedin.com/posts/inpharmedia_rarediseases-orphandrugs-competitiveintelligence-activity-7315225518990077952-CWh9?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_communication-leadership-businessetiquettes-activity-7312322760444104705-ZzW7?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_pharmacovigilance-drugsafety-psur-activity-7311228043170037760-jkLl?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_analyticalmethods-pharmaceuticaldevelopment-activity-7310876979824664578-LKVb?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_pharmaprofessionals-regulatoryexperts-pharmaceuticals-activity-7310133341549146112-uUah?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_pharmaceuticals-fda-regulatoryaffairs-activity-7309801103972319232-FPzY?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_pharmaceuticals-sterilization-biologicalindicators-activity-7309095238944362496-tCjH?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_m4q-r2-ctd-quality-guideline-activity-7308677046941990912-wct9?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_pharmaceuticals-changecontrol-qualityassurance-activity-7308328953373433858-kfbG?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_pharmacovigilance-drugsafety-healthcare-activity-7307959018918973440-u6Nc?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
https://www.linkedin.com/posts/inpharmedia_analyticalmethods-validation-qualityassurance-activity-7307596629283323906-iiQJ?utm_source=share&utm_medium=member_ios&rcm=ACoAAAt49_IBCWOydLF6K5lYA7k-cN3G1Z_cm_0
Showing the 12 most recent of 20 posts we hold for @inpharmedia. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 29 September 2026 — this entry's latest reading, not the date you are reading this.
“Inpharmedia” (@inpharmedia), 128 subscribers as measured 29 September 2026. Telegram Register, tgregister.com/channel/inpharmedia.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.